Skip to main content

IP 253 (Ranitidine Hydrochloride 150 mg)

Pill with imprint IP 253 is Orange, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Amneal Pharmaceuticals.

Ranitidine is used in the treatment of duodenal ulcer; gerd; duodenal ulcer prophylaxis; cutaneous mastocytosis; erosive esophagitis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IP 253

Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253 Front
Ranitidine hydrochloride 150 mg IP 253 Back
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253

Ranitidine Hydrochloride

Imprint
IP 253
Strength
150 mg
Color
Orange
Size
9.00 mm
Shape
Round
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals

Labelers / Repackagers

NDC Code Labeler / Repackager
53746-0253 (Discontinued) Amneal Pharmaceuticals LLC
65162-0253 (Discontinued) Amneal Pharmaceuticals LLC
63739-0489 (Discontinued) McKesson Packaging Services
68084-0717 (Discontinued) Amerisource Health Services
42291-0724 (Discontinued) AvKare, Inc.
66267-0188 (Discontinued) Nucare Pharmaceuticals Inc. (repackager)
68071-1321 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "IP 253"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.